Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Freeport-McMoRan Inc (FCX) is Carl Icahn’s Latest Target as It Embarks on Reducing Costs

According to a recent 13D filed with the Securities and Exchange Commission, Carl Icahn’s Icahn Capital has initiated a large activist stake in Freeport-McMoRan Inc (NYSE:FCX) through its affiliated funds. The new holding contains 88 million shares, representing about 8.46% of the company’s outstanding stock. However, the investor only holds 7.60 million shares, while the rest of the position is held in form of shares underlying forward contracts.

Carl Icahn as viking

Icahn is a renowned activist investor famed for his involvement in companies that usually brings significant changes such as shaking up the management, but, most importantly, creates shareholder value in the process. Aside from Freeport, regarding which Icahn also said it intends to discuss with management and request board representation, the activist’s latest target has been Cheniere Energy Inc. (NYSE:LNG), in which it disclosed a stake amassing 19.35 million shares and recently has obtained two board seats.

Carl Icahn
Carl Icahn
Icahn Capital LP

Most investors don’t understand hedge funds and indicators that are based on hedge funds’ activities. They ignore hedge funds because of their recent poor performance in the bull market. Our research indicates that hedge funds underperformed because they aren’t 100% long. Hedge fund fees are also very large compared to the returns generated and they reduce the net returns experienced by investors. We uncovered that hedge funds’ long positions actually outperformed the market. For instance the 15 most popular small-cap stocks among funds beat the S&P 500 Index by more than 80 percentage points since the end of August 2012. These stocks returned a cumulative of 123% vs. a 58% gain for the S&P 500 ETF (SPY) (see more details). That’s why we believe investors should pay attention to what hedge funds are buying (rather than what their net returns are).

Icahn’s move in Freeport-McMoRan Inc (NYSE:FCX) comes as the company has recently announced plans to further cut its spending and expenditure, which was well met by investors, sparking a 30% intraday rally of the stock.  The capital expenditure for mining and energy was slashed by 29% to $4 billion from the prior estimate that the company provided just a month earlier. Moreover, the sales outlook was reduced by 150 million lbs. per year for both 2016 and 2017. Also, the company announced a 20% reduction in estimated 2016 unit site production and delivery costs as compared to the estimated levels of 2015. While these measures might not go a long way in improving Freeport-McMoRan Inc (NYSE:FCX)’s income statement, they will surely improve the balance sheet and the statement of cash flow thereby ensuring investors that it can operate in a challenging environment. Prior to these cuts, Freeport-McMoRan Inc (NYSE:FCX) was operating in a highly unsustainable manner considering the copper market, as its capital expenditures for the first half of the year were near twice the operating cash flow.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.